An Increase in Mean Platelet Volume from Baseline Is Associated with Mortality in Patients with Severe Sepsis or Septic Shock

被引:111
作者
Kim, Chan Ho [1 ,2 ]
Kim, Seung Jun [1 ,2 ]
Lee, Mi Jung [3 ]
Kwon, Young Eun [3 ]
Kim, Yung Ly [3 ]
Park, Kyoung Sook [3 ]
Ryu, Han Jak [3 ]
Park, Jung Tak [3 ]
Han, Seung Hyeok [3 ]
Yoo, Tae-Hyun [3 ,4 ]
Kang, Shin-Wook [3 ,4 ]
Oh, Hyung Jung [3 ]
机构
[1] Catholic Kwandong Univ, Int St Marys Hosp, Coll Med, Dept Internal Med, Inchon, South Korea
[2] Yonsei Univ, Grad Sch Med, Dept Med, Seoul 120749, South Korea
[3] Yonsei Univ, Coll Med, Dept Internal Med, Seoul 120749, South Korea
[4] Yonsei Univ, Brain Korea PLUS Project Med Sci 21, Seoul 120749, South Korea
关键词
PERCUTANEOUS CORONARY INTERVENTION; GOAL-DIRECTED THERAPY; LONG-TERM MORTALITY; RHEUMATOID-ARTHRITIS; DISEASE-ACTIVITY; UNITED-STATES; VALIDATION; DYSFUNCTION; GUIDELINES; INFECTION;
D O I
10.1371/journal.pone.0119437
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Introduction Mean platelet volume (MPV) is suggested as an index of inflammation, disease activity, and anti-inflammatory treatment efficacy in chronic inflammatory disorders; however, the effect of MPV on sepsis mortality remains unclear. Therefore, we investigated whether the change in MPV between hospital admission and 72 hours (Delta MPV72h-adm) predicts 28-day mortality in severe sepsis and/or septic shock. Methods We prospectively enrolled 345 patients admitted to the emergency department (ED) who received standardized resuscitation (early goal-directed therapy) for severe sepsis and/or septic shock between November 2007 and December 2011. Changes in platelet indices, including Delta MPV72h-adm, were compared between survivors and non-survivors by linear mixed model analysis. The prognostic value of Delta MPV72h-adm for 28-day mortality was ascertained by Cox proportional hazards model analysis. Results Thirty-five (10.1%) patients died within 28 days after ED admission. MPV increased significantly during the first 72 hours in non-survivors (P = 0.001) and survivors (P < 0.001); however, the rate of MPV increase was significantly higher in non-survivors (P = 0.003). Nonetheless, the difference in the platelet decline rate over the first 72 hours did not differ significantly between groups (P = 0.360). In multivariate analysis, Delta MPV72h-adm was an independent predictor of 28-day mortality, after adjusting for plausible confounders (hazard ratio, 1.44; 95% confidence interval, 1.01-2.06; P = 0.044). Conclusions An increase in MPV during the first 72 hours of hospitalization is an independent risk factor for adverse clinical outcomes. Therefore, continuous monitoring of MPV may be useful to stratify mortality risk in patients with severe sepsis and/or septic shock.
引用
收藏
页数:13
相关论文
共 50 条
[31]   Increased colorectal permeability in patients with severe sepsis and septic shock [J].
Jorgensen, Vibeke L. ;
Nielsen, Steen L. ;
Espersen, Kurt ;
Perner, Anders .
INTENSIVE CARE MEDICINE, 2006, 32 (11) :1790-1796
[32]   Delay Within the 3-Hour Surviving Sepsis Campaign Guideline on Mortality for Patients With Severe Sepsis and Septic Shock [J].
Pruinelli, Lisiane ;
Westra, Bonnie L. ;
Yadav, Pranjul ;
Hoff, Alexander ;
Steinbach, Michael ;
Kumar, Vipin ;
Delaney, Connie W. ;
Simon, Gyorgy .
CRITICAL CARE MEDICINE, 2018, 46 (04) :500-505
[33]   IMPACT OF SEPSIS BUNDLE STRATEGY ON OUTCOMES OF PATIENTS SUFFERING FROM SEVERE SEPSIS AND SEPTIC SHOCK IN CHINA [J].
Wang, Zhen ;
Xiong, Yingxia ;
Schorr, Christa ;
Dellinger, R. P. .
JOURNAL OF EMERGENCY MEDICINE, 2013, 44 (04) :735-741
[34]   Outcomes in severe sepsis and patients with septic shock do not matter! PIRO is a score to treat severe septic and septic shock patients not to measure outcomes reply [J].
Adrie, Christophe ;
Zahar, Jean Ralph ;
Timsit, Jean-Francois .
CRITICAL CARE MEDICINE, 2012, 40 (02) :707-708
[35]   Systolic blood pressure variability in patients with early severe sepsis or septic shock: a prospective cohort study [J].
Tang, Yi ;
Sorenson, Jeff ;
Lanspa, Michael ;
Grissom, Colin K. ;
Mathews, V. J. ;
Brown, Samuel M. .
BMC ANESTHESIOLOGY, 2017, 17
[36]   The epidemiology of, and risk factors for, mortality from severe sepsis and septic shock in a tertiary-care university hospital setting [J].
Khwannimit, B. ;
Bhurayanontachai, R. .
EPIDEMIOLOGY AND INFECTION, 2009, 137 (09) :1333-1341
[37]   Levosimendan reduces mortality in patients with severe sepsis and septic shock: A meta-analysis of randomized trials [J].
Zangrillo, Alberto ;
Putzu, Alessandro ;
Monaco, Fabrizio ;
Oriani, Alessandro ;
Frau, Giovanna ;
De Luca, Monica ;
Di Tomasso, Nora ;
Bignami, Elena ;
Lomivorotov, Vladimir ;
Likhvantsev, Valery ;
Landoni, Giovanni .
JOURNAL OF CRITICAL CARE, 2015, 30 (05) :908-913
[38]   Prompt admission to intensive care is associated with improved survival in patients with severe sepsis and/or septic shock [J].
Li, Qiang ;
Wang, Jiajiong ;
Liu, Guomin ;
Xu, Meng ;
Qin, Yanguo ;
Han, Qin ;
Liu, He ;
Wang, Xiaonan ;
Wang, Zonghan ;
Yang, Kerong ;
Gao, Chaohua ;
Wang, Jin-cheng ;
Zhang, Zhongheng .
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2018, 46 (10) :4071-4081
[39]   Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock [J].
Mikkelsen, Mark E. ;
Miltiades, Andrea N. ;
Gaieski, David F. ;
Goyal, Munish ;
Fuchs, Barry D. ;
Shah, Chirag V. ;
Bellamy, Scarlett L. ;
Christie, Jason D. .
CRITICAL CARE MEDICINE, 2009, 37 (05) :1670-1677
[40]   Soluble TREM-1 Serum Level can Early Predict Mortality of Patients with Sepsis, Severe Sepsis and Septic Shock [J].
Jedynak, Monika ;
Siemiatkowski, Andrzej ;
Mroczko, Barbara ;
Groblewska, Magdalena ;
Milewski, Robert ;
Szmitkowski, Maciej .
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2018, 66 (04) :299-306